Unlock instant, AI-driven research and patent intelligence for your innovation.

Sustained release formulations using non-aqueous emulsions

A non-aqueous, emulsion technology, applied in non-active ingredients medical preparations, medical preparations containing active ingredients, drug delivery, etc., can solve problems such as low viscosity of fluorocarbons

Pending Publication Date: 2022-07-15
REGENERON PHARM INC
View PDF49 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] 3. Fluorocarbons have low viscosity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sustained release formulations using non-aqueous emulsions
  • Sustained release formulations using non-aqueous emulsions
  • Sustained release formulations using non-aqueous emulsions

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0096] Example 1: Synthesis of blank microspheres by H / F based bulk emulsion.

[0097] Materials and methods

[0098] Oil and water based emulsion systems are often used for polymer microparticle or nanoparticle synthesis, where hydrophobic polymer materials are dissolved in an organic phase and dispersed in an aqueous continuous phase. However, for water-soluble polymers such as PEG, carboxymethyl cellulose (CMC), and polymers that are readily hydrolyzed in the presence of water, including polyanhydrides, aliphatic polyesters with short midblocks (eg, polylactic acid) As with certain poly(amino acids), such as poly(glutamic acid), conventional water-based emulsion systems are not ideal. The following examples demonstrate the utility of the disclosed H / F emulsion systems for producing the water-soluble or water-degradable polymer microparticles described above. In some embodiments, those polymers are first dissolved in a hydrocarbon solvent comprising polar solvents such a...

example 2

[0105] Example 2: Effect of homogenization speed.

[0106] Materials and methods

[0107] One (1) mL of DCM with 30% w / v or 40% w / v POE was added to 9 mL of FC-40 with 0.5% (w / w) FS FC-40 and mixed with VWR 7mm x The VWR Handheld Homogenizer 200 for the 95mm sawtooth generator probe operates at three homogenization speeds, namely, low (approximately 50% of full power), medium (approximately 60% of full power) and high (approximately 70% of full power) ) for emulsification. The resulting emulsion was stirred under vacuum. The formed microspheres were washed and dried under vacuum.

[0108] result

[0109] as in image 3 shows that for a POE of 30%, low homogenization speed yields larger microsphere sizes, while high homogenization speed yields smaller sizes (Table 2). 40% of POEs showed the same trend. These results show that adjusting the homogenization speed can control the microsphere size.

[0110] Table 2: Microsphere sizes of POE spheres produced at different ...

example 3

[0112] Example 3: General procedure for encapsulation of protein SDPs in POE microspheres by S / H / F based bulk emulsion method.

[0113] Materials and methods

[0114] as in Figure 4 As shown in , the bulk emulsion synthesis can be divided into three steps: formulation, emulsification, and hardening. Due to the different parameters used in these three steps, the properties of the products will vary. The general procedure is described as follows:

[0115] For formulation, 10%-30% w / w total solids weight of VEGF Trap SDP (or fluorescently labeled SDP (F-SDP) for fluorescence imaging) was dispersed in 500 μL by vortexing followed by sonication for 5 minutes 10-35% w / v POE in ethyl acetate. These suspensions were then added to 9.5 mL of FC-40 with 0.1-0.5% w / w FS. Emulsification can be accomplished by stirring, vortexing, or homogenizing using a benchtop homogenizer. The structure of the emulsion is Figure 5 displayed in. Immediately after emulsification, in-process ali...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

A non-aqueous emulsion process for producing polymeric microparticles or polymer coated microparticles is provided. A method produces a sustained release particulate composition by combining a protein powder and a polymer into a hydrocarbon solvent to form a non-aqueous first solution; and adding the first solution to a second solution to form a non-aqueous emulsion, where the second solution includes a fluorocarbon liquid and a fluorine-containing surfactant, the non-aqueous emulsion including a plurality of emulsion hydrocarbon droplets in the fluorocarbon liquid. A subsequent particulate hardening process comprises the steps of: removing the hydrocarbon solvent from the formed emulsion droplets, which can be accomplished by vaporizing the hydrocarbon under ambient conditions while stirring; or accelerated hardening by vacuum or by adding a hydrofluoroester as a co-solvent to the fluorocarbon. The fluorocarbon liquid is removed and washed with an additional fluorocarbon liquid to separate the sustained release microparticles, wherein the sustained release microparticles include one or more protein nuclei and a polymer skin layer.

Description

technical field [0001] Aspects of the present invention generally relate to pharmaceutical microsphere formulations and methods of making the same using non-aqueous emulsion systems. Background technique [0002] Sustained-release delivery of therapeutic proteins to biologically relevant targets is useful for the treatment of medical conditions such as cancer, cardiovascular disease, vascular conditions, orthopedic conditions, dental conditions, wounds, autoimmune diseases, gastrointestinal disorders, and ocular diseases. Expected. Biocompatible and biodegradable polymers and other implantable delivery devices have been used for decades for controlled and prolonged delivery of drugs. For example, in some polymer-based delivery devices, the therapeutic drug is slowly released as the polymer degrades over time. [0003] Sustained release may be desirable for patient compliance. In particular, it may be beneficial to reduce the number of injections, especially when injection...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K9/16A61K38/17A61K47/14A61K47/18
CPCA61K38/179A61K9/1647A61K47/14A61K47/18A61K9/0019A61K9/5031A61K9/1682
Inventor 陈泓钧赵一鸣
Owner REGENERON PHARM INC